Givaudan strengthens research efforts on skin microbiome via Premium Beauty
26 February 2018
Givaudan Active Beauty is continuing its investments in skin microbiome research. The company has acquired a new automatized equipment for high speed genomic screening with the aim to accelerate the development of innovative cosmetic ingredients designed to activate, protect or balance the skin microbiota.
Givaudan continues to invest in its Active Beauty business unit and its metagenomics platform to boost its pioneering position in the microbiome market. Givaudan, which claims to be the only fragrance company with in-house microbiome research capabilities, says these new strategic investments will help the company to remain one of the leaders in the development of new actives focusing on the skin microbiome.
Follow us on Linkedin!